Biotechnology
Innovations in cancer immunotherapy: Bi-specific T cell engagers
Bi-specific T cell engagers are poised to become key immunotherapy treatments due to simpler production and new safety advances.
Certificate order confirmation
Your Order is Being Processed
Thank you for ordering your CAS REGISTRY® Innovators Program certificate.
Certificates are typically delivered within 10-15 business days.
If you have any questions contact the CAS Customer Center.
Latest from CAS Insights™
Biotechnology
Microelectronics frontiers: insights into emerging technologies
How can researchers identify emerging trends in a massive field like microelectronics? Our analysis reveals breakthroughs across materials, devices, applications, and fabrication methods.
Biotechnology
The future of epigenetics: Emerging technologies and clinical applications
Epigenetics is the study of changes in gene expression that don’t alter DNA sequences. Understanding these processes is driving more personalized medicine and innovative therapies.